The Incidence of Other Primary Cancers in Patients with Cutaneous Lymphoma.

Young Jae Kim, Ho Jeong Shin, Chong Hyun Won, Sung Eun Chang, Mi Woo Lee, Jee Ho Choi, Woo Jin Lee
Author Information
  1. Young Jae Kim: Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  2. Ho Jeong Shin: Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  3. Chong Hyun Won: Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  4. Sung Eun Chang: Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  5. Mi Woo Lee: Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  6. Jee Ho Choi: Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  7. Woo Jin Lee: Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ORCID

Abstract

BACKGROUND: Skin cancer is the most common other primary cancer in patients with lymphoma. However, an intriguing association between cutaneous lymphoma and other primary cancers has been suggested in a few studies.
OBJECTIVE: This study investigated other primary cancers in patients with cutaneous lymphoma to evaluate the risk for occurrence of each type of cancer.
METHODS: We screened for other primary cancers in 428 patients with cutaneous lymphoma. Clinical features were analyzed according to the lineage and origin of the lymphomas. We calculated the standardized incidence ratio with statistical analysis for each group according to age.
RESULTS: Among 330 patients with cutaneous T cell lymphoma and 98 with cutaneous B cell lymphoma, a total of 43 cancers in 38 patients were finally included. Other primary cancers were prevalent in patients with cutaneous B cell lymphoma and patients with secondary cutaneous lymphoma. However, those differences were not significant when the age was calibrated by multiple logistic regression. Metachronously higher standardized incidence ratios were observed for primary lung (standardized incidence ratio [SIR], 14.81; 95% confidence interval [CI], 3.05~39.54), skin (SIR, 68.05; 95% CI, 14.03~181.62), and breast (SIR, 12.91; 95% CI, 1.56~41.41) cancers with statistical significance.
CONCLUSION: Other primary cancers more preferentially occurred in patients with cutaneous lymphoma. Clinicians should carefully examine patients with cutaneous lymphoma for other cancers, especially lung, skin, and breast cancers.

Keywords

References

  1. Br J Dermatol. 2010 Sep;163(3):564-71 [PMID: 20408834]
  2. Breast Cancer Res Treat. 2013 Jun;139(2):301-10 [PMID: 23624778]
  3. Clin Diagn Lab Immunol. 1999 Jan;6(1):79-84 [PMID: 9874668]
  4. J Cancer Prev. 2016 Dec;21(4):227-234 [PMID: 28053956]
  5. J Immunol. 1995 Feb 1;154(3):1491-8 [PMID: 7822812]
  6. J Am Acad Dermatol. 1984 Feb;10(2 Pt 1):197-204 [PMID: 6609176]
  7. Cancer Res Treat. 2017 Apr;49(2):292-305 [PMID: 28279062]
  8. Cancer. 1989 Apr 15;63(8):1612-5 [PMID: 2924268]
  9. J Invest Dermatol. 2000 Jul;115(1):62-5 [PMID: 10886509]
  10. Cancer. 2009 Jul 1;115(13):2939-48 [PMID: 19408343]
  11. J Am Acad Dermatol. 2016 Feb;74(2):333-40 [PMID: 26584878]
  12. Clin Exp Dermatol. 2013 Jul;38(5):457-63 [PMID: 23611304]
  13. Clin Lymphoma Myeloma. 2008 Apr;8(2):100-5 [PMID: 18501103]
  14. IARC Sci Publ. 1987;(82):1-406 [PMID: 2577937]
  15. Biochem J. 2016 Oct 1;473(19):2973-94 [PMID: 27679857]
  16. Arch Dermatol. 1999 Nov;135(11):1381-5 [PMID: 10566838]
  17. Br J Dermatol. 2015 Jul;173(1):134-45 [PMID: 25556641]
  18. Br J Dermatol. 2017 Jul;177(1):287-289 [PMID: 27641754]
  19. J Eur Acad Dermatol Venereol. 2016 Oct;30(10 ):1682-1685 [PMID: 27501224]
  20. Br J Dermatol. 2011 May;164(5):1071-7 [PMID: 21083546]
  21. Am J Clin Dermatol. 2016 Feb;17 (1):71-7 [PMID: 26386881]
  22. Arch Dermatol. 2007 Jan;143(1):45-50 [PMID: 17224541]

Word Cloud

Created with Highcharts 10.0.0lymphomapatientscutaneouscancersprimarycancerstandardizedincidencecell95%SkinHoweveraccordingratiostatisticalageBlung14skinSIRCIbreastIncidenceLymphomaBACKGROUND:commonintriguingassociationsuggestedstudiesOBJECTIVE:studyinvestigatedevaluateriskoccurrencetypeMETHODS:screened428ClinicalfeaturesanalyzedlineageoriginlymphomascalculatedanalysisgroupRESULTS:Among330T98total4338finallyincludedprevalentsecondarydifferencessignificantcalibratedmultiplelogisticregressionMetachronouslyhigherratiosobserved[SIR]81confidenceinterval[CI]305~3954680503~181621291156~4141significanceCONCLUSION:preferentiallyoccurredClinicianscarefullyexamineespeciallyPrimaryCancersPatientsCutaneousNeoplasms

Similar Articles

Cited By